SCHEMBL1974627

SCHEMBL1974627

CCOC(=O)c1c(C)cc(=O)n(-c2ccccc2)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
MAPT P10636 5/20 0.55
ALDH1A1 P00352 3/20 0.55
GAA P10253 1/20 0.55
RECQL P46063 1/20 0.53
THRB P10828 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
PDE4D Q08499 1/20 0.52
AR P10275 1/20 0.51
TP53 P04637 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HIF1A Q16665 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CHEK1 O14757 1/20 0.47
AURKA O14965 1/20 0.47
NTRK1 P04629 1/20 0.47
FYN P06241 1/20 0.47
MET P08581 1/20 0.47
PDGFRB P09619 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1974506 0.88 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11465285 0.86 KMT2A (0.47) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL11455487 0.86 MAPK1 (0.62) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL1978820 0.84 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL679393 0.83 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11789226 0.82 MAPT (0.60) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL1976260 0.82 GAA (0.52) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11428841 0.80 RECQL (0.62) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11465301 0.78 APLNR (0.42) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL1717720 0.78 RECQL (0.67) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513061-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. Lundbeck A/S (DK) 2012-10-24 EP disclosed
US-8207347-B2 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-06-26 US disclosed
US-8207347-B2 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-06-26 US disclosed
US-8207347-B2 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-06-26 US disclosed
WO-2011072691-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-23 WO disclosed
WO-2011072691-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-23 WO disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 US disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 US disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144164-A1 Pyridone derivatives as NK3 antagonists KCNK3, GRIK3, KCND3 MEN1 2098/4885KMT2A 1757/4885MAPT 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.